Oxidative stress in genetic mouse models of Parkinson’s disease M Varçin, E Bentea, Y Michotte, S Sarre
Oxidative medicine and cellular longevity 2012, 2012
119 2012 The proteasome inhibition model of Parkinson’s disease E Bentea, L Verbruggen, A Massie
Journal of Parkinson's Disease 7 (1), 31-63, 2017
105 2017 The cystine‐glutamate exchanger (xCT, Slc7a11) is expressed in significant concentrations in a subpopulation of astrocytes in the mouse brain S Ottestad‐Hansen, QX Hu, VV Follin‐Arbelet, E Bentea, H Sato, ...
Glia 66 (5), 951-970, 2018
79 2018 Measurement of lactate levels in postmortem brain, iPSCs, and animal models of schizophrenia CR Sullivan, CA Mielnik, A Funk, SM O’Donovan, E Bentea, M Pletnikov, ...
Scientific reports 9 (1), 1-7, 2019
62 2019 Nigral proteasome inhibition in mice leads to motor and non-motor deficits and increased expression of Ser129 phosphorylated α-synuclein E Bentea, A Van der Perren, J Van Liefferinge, A El Arfani, G Albertini, ...
Frontiers in behavioral neuroscience 9, 68, 2015
50 2015 Comparative analysis of antibodies to xCT (Slc7a11): Forewarned is forearmed J Van Liefferinge, E Bentea, T Demuyser, G Albertini, V Follin‐Arbelet, ...
Journal of Comparative Neurology 524 (5), 1015-1032, 2016
48 2016 Disruption of the HPA-axis through corticosterone-release pellets induces robust depressive-like behavior and reduced BDNF levels in mice T Demuyser, E Bentea, L Deneyer, G Albertini, A Massie, I Smolders
Neuroscience letters 626, 119-125, 2016
45 2016 Kinase network dysregulation in a human induced pluripotent stem cell model of DISC1 schizophrenia E Bentea, EAK Depasquale, SM O’Donovan, CR Sullivan, M Simmons, ...
Molecular omics 15 (3), 173-188, 2019
42 2019 Connectivity analyses of bioenergetic changes in schizophrenia: Identification of novel treatments CR Sullivan, CA Mielnik, SM O’Donovan, AJ Funk, E Bentea, ...
Molecular neurobiology 56 (6), 4492-4517, 2019
41 2019 In-depth behavioral characterization of the corticosterone mouse model and the critical involvement of housing conditions T Demuyser, L Deneyer, E Bentea, G Albertini, J Van Liefferinge, ...
Physiology & behavior 156, 199-207, 2016
37 2016 Absence of system xc-in mice decreases anxiety and depressive-like behavior without affecting sensorimotor function or spatial vision E Bentea, T Demuyser, J Van Liefferinge, G Albertini, L Deneyer, J Nys, ...
Progress in Neuro-Psychopharmacology and Biological Psychiatry 59, 49-58, 2015
36 2015 Genetic deletion of xCT attenuates peripheral and central inflammation and mitigates LPS-induced sickness and depressive-like behavior in mice. G Albertini, L Deneyer, S Ottestad-Hansen, Y Zhou, G Ates, L Walrave, ...
Glia, 2018
33 2018 Corticostriatal dysfunction and social interaction deficits in mice lacking the cystine/glutamate antiporter E Bentea, A Villers, C Moore, AJ Funk, SM O’Donovan, L Verbruggen, ...
Molecular psychiatry 26 (9), 4754-4769, 2021
32 2021 Validation of the 6Hz refractory seizure mouse model for intracerebroventricularly administered compounds L Walrave, K Maes, J Coppens, E Bentea, A Van Eeckhaut, A Massie, ...
Epilepsy research 115, 67-72, 2015
30 2015 Alterations in the motor cortical and striatal glutamatergic system and d-serine levels in the bilateral 6-hydroxydopamine rat model for Parkinson's disease A El Arfani, G Albertini, E Bentea, T Demuyser, A Van Eeckhaut, ...
Neurochemistry international 88, 88-96, 2015
29 2015 Absence of system xc− on immune cells invading the central nervous system alleviates experimental autoimmune encephalitis E Merckx, G Albertini, M Paterka, C Jensen, P Albrecht, M Dietrich, ...
Journal of neuroinflammation 14 (1), 1-16, 2017
27 2017 Anticonvulsant and antiepileptogenic effects of system K Leclercq, JV Liefferinge, G Albertini, M Neveux, S Dardenne, ...
Epilepsia 60 (7), 1412-1423, 2019
24 2019 MPTP-induced parkinsonism in mice alters striatal and nigral xCT expression but is unaffected by the genetic loss of xCT E Bentea, MD Sconce, MJ Churchill, J Van Liefferinge, H Sato, CK Meshul, ...
Neuroscience letters 593, 1-6, 2015
20 2015 NMDA receptor antagonism potentiates the L-DOPA-induced extracellular dopamine release in the subthalamic nucleus of hemi-parkinson rats A El Arfani, E Bentea, N Aourz, B Ampe, P De Deurwaerdère, ...
Neuropharmacology 85, 198-205, 2014
20 2014 Altered vesicular glutamate transporter expression in human temporal lobe epilepsy with hippocampal sclerosis J Van Liefferinge, CJ Jensen, G Albertini, E Bentea, T Demuyser, ...
Neuroscience letters 590, 184-188, 2015
18 2015 